Bexarotene - an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences-Reference-Cited by-同舟云学术

Bexarotene - an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences

Published:2003-10 Issue:10 Volume:1 Page:785-789
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:

Author:

Bohmeyer J.,Stadler R.,Kremer A.,Nashan D.,Muche M.,Gellrich S.,Luger T.,Sterry W.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1439-0353.2003.03711.x/fullpdf

Reference27 articles.

1. Prospective randomized multicenter clinical trial on the use of interferon alfa-2a plus acitretin versus interferon alfa-2a plus PUVA in patients with cutaneous T-cell lymphoma (CTCL) stage I and II;Stadler;Blood,1998

2. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer;Willemze;Blood,1997

3. Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology;Weinstock;JAMA,1988

4. Prognosis in cutaneous T-cell lymphoma by skin stage: long term survival in 489 patients;Zackheim;J Am Acad Dermatol,1999

5. Prognostic factors in erythrodermic mycosis fungoides and the Sé zary syndrome;Kim;Arch Dermatol,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interventions for mycosis fungoides;Cochrane Database of Systematic Reviews;2020-07-07

2. Interventions for mycosis fungoides;COCHRANE DB SYST REV;2020

3. Chemical evaluation and cytotoxic mechanism investigation of Clinacanthus nutans extract in lymphoma SUP-T1 cells;Environmental Toxicology;2018-09-06

4. Development and Validation of a Novel Stability Indicating UPLC Method for Analysis of Related Compounds and Assay of Bexarotene, an Anti-Cancer Agent;Chromatographia;2017-08-07

5. Retinoids;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15